All News
Dr. Judith Tsui has been awarded two grants from the National Institute on Drug Abuse for opioid treatment programs.
Recent research shows that the same mechanisms that aggressive prostate cancer cells manipulate to elude therapy can be used against them, forcing them to shapeshift back into their more treatable form.
She has received a prestigious American Society of Clinical Oncology Career Development Award for work on a new biomarker for triple-negative breast cancer.
Larson will chair the committee on the Examination of the Direct Neurocognitive Effects of SARS-CoV-2 Infection Across the Lifespan and Implications for U.S. Military and Veteran Health.
Alyssa was chosen after an extensive and competitive nationwide search and we are so incredibly lucky as a department to have her on our executive leadership team.
A new research trial will compare two drugs used to treat post-arrest shock, a condition affecting 70% of survivors.